Jin Medical International Ltd.
ZJYL
$1.85
-$0.13-6.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.96% | -31.96% | -104.96% | -104.96% | 69.26% |
| Total Depreciation and Amortization | -17.19% | -17.19% | 20.93% | 20.93% | 59.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 239.32% | 239.32% | 137.64% | 137.64% | -290.96% |
| Change in Net Operating Assets | 59.28% | 59.28% | 236.41% | 236.41% | -285.29% |
| Cash from Operations | 127.17% | 127.17% | 5,024.00% | 5,024.00% | -446.39% |
| Capital Expenditure | -7,381.37% | -7,381.37% | -2,353.59% | -2,353.59% | 40.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.82% | 61.82% | 59.72% | 59.72% | -841.02% |
| Cash from Investing | -23.08% | -23.08% | -0.95% | -0.95% | -717.31% |
| Total Debt Issued | -14.47% | -14.47% | 65.73% | 65.73% | 164.45% |
| Total Debt Repaid | -26.48% | -26.48% | -- | -- | 3.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.60% | -56.60% | -18.37% | -18.37% | 575.11% |
| Foreign Exchange rate Adjustments | -40.39% | -40.39% | -789.60% | -789.60% | 185.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -396.78% | -396.78% | 53.99% | 53.99% | 57.89% |